JP2005508160A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508160A5 JP2005508160A5 JP2003529971A JP2003529971A JP2005508160A5 JP 2005508160 A5 JP2005508160 A5 JP 2005508160A5 JP 2003529971 A JP2003529971 A JP 2003529971A JP 2003529971 A JP2003529971 A JP 2003529971A JP 2005508160 A5 JP2005508160 A5 JP 2005508160A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- compound
- activity
- cardiovascular disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32301801P | 2001-09-18 | 2001-09-18 | |
| PCT/US2002/029353 WO2003025199A2 (en) | 2001-09-18 | 2002-09-17 | Mid 4460, a human tyrosine phosphatase family member and uses therefor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005508160A JP2005508160A (ja) | 2005-03-31 |
| JP2005508160A5 true JP2005508160A5 (cg-RX-API-DMAC7.html) | 2006-01-05 |
Family
ID=23257441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003529971A Pending JP2005508160A (ja) | 2001-09-18 | 2002-09-17 | ヒトチロシンホスファターゼファミリーメンバーであるｍｉｄ４４６０およびその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7157240B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1427857A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005508160A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2002336551A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003025199A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1848742A1 (en) * | 2005-01-28 | 2007-10-31 | Attogen, Inc. | Anti-prl-3 antibodies and methods of use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0789771A2 (en) * | 1993-09-01 | 1997-08-20 | Ludwig Institute For Cancer Research | Primary structure and functional expression of nucleotide sequences for novel protein tyrosine phosphatases |
| US6607879B1 (en) * | 1998-02-09 | 2003-08-19 | Incyte Corporation | Compositions for the detection of blood cell and immunological response gene expression |
| US6258582B1 (en) * | 1998-09-30 | 2001-07-10 | Millennium Pharmaceuticals, Inc. | CSAPTP nucleic acid molecules and uses therefor |
| CA2296792A1 (en) * | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
| WO2000075339A1 (en) | 1999-06-03 | 2000-12-14 | Cold Spring Harbor Laboratory | Substrate trapping protein tyrosine phosphatases |
| US20020009762A1 (en) | 2000-02-14 | 2002-01-24 | Flint Andrew J. | Assay for protein tyrosine phosphatases |
| CA2411601A1 (en) | 2000-06-05 | 2001-12-13 | Avalon Pharmaceuticals | Cancer gene determination and therapeutic screening using signature gene sets |
-
2002
- 2002-09-17 US US10/245,539 patent/US7157240B2/en not_active Expired - Fee Related
- 2002-09-17 EP EP02773408A patent/EP1427857A4/en not_active Withdrawn
- 2002-09-17 AU AU2002336551A patent/AU2002336551A1/en not_active Abandoned
- 2002-09-17 JP JP2003529971A patent/JP2005508160A/ja active Pending
- 2002-09-17 WO PCT/US2002/029353 patent/WO2003025199A2/en not_active Ceased